3rd Quarter - Report

JEFFREY J. KIMBELL & ASSOCIATES, INC. for EAGLE PHARMACEUTICALS INC.

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S 934/HR 2430, FDA Reauthorization Act of 2017; Issues related to the Orphan Drug Act.

LobbyistCovered position, as disclosed
JOHN HERZOG Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President
JEFFREY J KIMBELL —
JODIE LOCKHART —
KEITH STUDDARD Legislative Director, Rep. Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.